![](https://investorshub.advfn.com/uicon/314626.png?cb=1485173186)
Sunday, April 22, 2018 1:29:33 PM
Les, if you to write the article now, any change you want to make about OMHE valuation?
My last paragraph on Omni in that article sums it up...
https://seekingalpha.com/instablog/12862651-les-mezei/5093661-four-long-term-penny-stock-picks-2017-gained-354-percent-still-buy" rel="nofollow" target="_blank" >https://seekingalpha.com/instablog/12862651-les-mezei/5093661-four-long-term-penny-stock-picks-2017-gained-354-percent-still-buy[tag]Four Long Term Penny Stock Picks For 2017 Gained 354% - Still A Buy
[/tag]
I believe that this company, as of today, is significantly undervalued. If they are on path next summer for $16.5 million in revenue, I would target them for a pps of at least $.13/share. It could be more than double that if they complete their share restructuring. If we start seeing some real progress on their pharma grade drug, share appreciation could be huge. Consequently, I am again recommending them for a long term hold.
There are a lot of "if's" in there. So far we haven't gotten any answers. Until we do, I can't recommend a "Buy" but there is also no reason yet to change from a "hold" other than confidence in Andrey's management.
Les
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM